An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease
Open Access
- 12 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Background and Aims: The management of IBD entails the use of various treatments (nutrition, medications, and surgery) in order to induce and maintain remission. The assessment of IBD disease activity is based on a combination of symptoms, clinical findings, imaging, and endoscopic procedures. As in any disease, reliable assessment of disease activity or severity is required in order to plan relevant follow-up, decide on appropriate investigations, determine the best treatment option and subsequently assess response to treatment. It is important for proper documentation, follow-up, assessment of response to treatment and communication, especially in patients with IBD, to talk the same language by using validated and widely used scores for disease activity, endoscopic and radiologic activity, and patient reported outcomes both for clinical practice and research. This review aims to highlight key tools available for the assessment of disease activity or severity in individuals (especially children) with IBD. Methods: A literature search was performed using MEDLINE, Pubmed, and the Cochrane Library with the last search date of August 2020. Tools evaluating disease severity across various aspects (clinical, endoscopic, and radiological) were identified and discussed. Those tools validated and specific for children with IBD were included were available. Results: Over time a number of scoring systems have been developed to quantify clinical, endoscopic and imaging assessments in individuals with IBD. While some are exclusively for children or adults, others appear to have relevance to all age groups. In addition, some tools developed in adult populations are utilized in children, but have not expressly been validated in this age group. Conclusions: Although some available scoring tools are appropriate for children with IBD, others require consideration. The development and use of pediatric-specific tools is relevant and appropriate to optimal care of children and adolescents with IBD.This publication has 64 references indexed in Scilit:
- Perception gaps between patients with ulcerative colitis and healthcare professionals: an online surveyBMC Gastroenterology, 2012
- Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and healthGut, 2011
- Short pediatric Crohnʼs disease activity index for quality improvement and observational researchInflammatory Bowel Diseases, 2011
- Development and Assessment of a Modified Pediatric Crohn Disease Activity IndexJournal of Pediatric Gastroenterology and Nutrition, 2010
- Measuring Severity in Chronic DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2010
- Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative ColitisInflammatory Bowel Diseases, 2008
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- A clinical scoring system for chronic inflammatory bowel disease in childrenDigestive Diseases and Sciences, 1979